Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 28;11(5):1170-1183.
doi: 10.14218/JCTH.2022.00013S. Epub 2023 May 4.

Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review

Affiliations
Review

Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review

Xudong Zhao et al. J Clin Transl Hepatol. .

Abstract

Hepatocellular carcinoma (HCC) being a leading cause of cancer-related death, has high associated mortality and recurrence rates. It has been of great necessity and urgency to find effective HCC diagnosis and treatment measures. Studies have shown that microvascular invasion (MVI) is an independent risk factor for poor prognosis after hepatectomy. The abnormal expression of biomacromolecules such as circ-RNAs, lncRNAs, STIP1, and PD-L1 in HCC patients is strongly correlated with MVI. Deregulation of several markers mentioned in this review affects the proliferation, invasion, metastasis, EMT, and anti-apoptotic processes of HCC cells through multiple complex mechanisms. Therefore, these biomarkers may have an important clinical role and serve as promising interventional targets for HCC. In this review, we provide a comprehensive overview on the functions and regulatory mechanisms of MVI-related biomarkers in HCC.

Keywords: Biomarkers; Hepatocellular carcinoma; Microvascular invasion; Molecular mechanism; Progress.

PubMed Disclaimer

Conflict of interest statement

JWPY has been an editorial board member of Journal of Clinical and Translational Hepatology since 2021. The other authors have no conflict of interests related to this publication.

Figures

Fig. 1
Fig. 1. Effect of biomarkers associated with MVI of HCC and their mechanisms.
Aberrantly expressed biomarkers in HCC with MVI can be involved in the process of cell proliferation and apoptosis, invasion and metastasis, angiogenesis, EMT, immune escape. BOP1, block of proliferation 1; EMT, epithelial-mesenchymal transition; FN1, fibronectin 1; FGF5, fibroblast growth factor 5; HCC, hepatocellular carcinoma; LncRNA MVIH, lncRNA associated with microvascular invasion; MAGL, monoacylglycerol lipase; MTDH, metadherin; MVI, microvascular invasion; PD-L1, programmed cell death-ligand 1; PIVKA-II, prothrombin induced by vitamin K absence II; STIP1, stress-induced phosphoprotein 1; STMN1, stathmin 1; USP7, ubiquitin-specific protease 7.
Fig. 2
Fig. 2. Biological role of the biomarkers in the development of EMT.
E-cadherin is an epithelial marker, and N-cadherin, vimentin, Snail, nuclear β-catenin and MMP-9 are mesenchymal markers in EMT-related proteins. In the pathological process of HCC with MVI, several markers can induce EMT by increasing the expression of mesenchymal markers and reducing the expression of epithelial markers, thereby promoting the migration, invasion, and metastasis of HCC cells. BOP1, block of proliferation 1; DDR1, discoidin domain receptor 1; EMT, epithelial-mesenchymal transition; HCC, hepatocellular carcinoma; MAGL, monoacylglycerol lipase; MTDH, metadherin; MVI, microvascular invasion; PIVKA-II, prothrombin induced by vitamin K absence II; STIP1, stress-induced phosphoprotein 1; STMN1, stathmin 1.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Zheng Z, Guan R, Jianxi W, Zhao Z, Peng T, Liu C, et al. Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. J Oncol. 2022;2022:9567041. doi: 10.1155/2022/9567041. - DOI - PMC - PubMed
    1. Zhang X, Li J, Shen F, Lau W. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2018;33(2):347–354. doi: 10.1111/jgh.13843. - DOI - PubMed
    1. Rodríguez-Perálvarez M, Luong T, Andreana L, Meyer T, Dhillon A, Burroughs A. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20(1):325–339. doi: 10.1245/s10434-012-2513-1. - DOI - PubMed
    1. Chen Z, Zhang X, Wang H, Chai Z, Sun J, Guo W, et al. Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis. HPB. 2019;21(8):935–944. doi: 10.1016/j.hpb.2019.02.003. - DOI - PubMed